Pyoderma gangrenosum following vaccination against coronavirus disease-2019: a case report
- PMID: 35567368
- PMCID: PMC9348276
- DOI: 10.1111/ijd.16255
Pyoderma gangrenosum following vaccination against coronavirus disease-2019: a case report
Figures
Comment on
-
Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective.Vaccines (Basel). 2021 Aug 25;9(9):944. doi: 10.3390/vaccines9090944. Vaccines (Basel). 2021. PMID: 34579181 Free PMC article. Review.
References
-
- Skopis M, Bag‐Ozbek A. Pyoderma gangrenosum: a review of updates in diagnosis, pathophysiology and management. J 2021; 4: 367–375.
-
- Khatri ML, Shafi M, Benghazil M, et al. Pyoderma gangrenosum in childhood. Indian J Dermatol Venereol Leprol 1995; 61: 96–98. - PubMed
-
- Elkhatib R, Giunta G, Hanssens V, et al. Case report of two patients with COVID‐19 and sacral pressure injuries associated with pyoderma gangrenosum. Adv Skin Wound Care 2021; 34: 438–443. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
